Results 61 to 70 of about 10,840 (135)

Prevalence, Mortality, Antifungal Resistance, and Risk Factors of Candidemia Among Cancer Patients in a Single Center of Southern China: A 10-Year Retrospective Study

open access: yesJournal of Tropical Medicine
Cancer patients are at a high risk of Candida infections, and candidemia may aggravate the prognosis among patients with cancers. To investigate the incidence, mortality, risk factors, and antifungal resistance of candidemia among cancer patients, 100 ...
Limei Chen   +8 more
doaj   +1 more source

A 7-year study of the distribution of nosocomial candidemia in children with cancer

open access: yesThe Turkish Journal of Pediatrics, 2015
Candidemia is an important cause of morbidity and mortality in cancer patients. The incidence of candidemia has been reported to have shifted toward nonalbicans species.
İlker Devrim   +10 more
doaj  

T2Candida® to guide antifungal and lengh of treatment of candidemia in a pediatric multivisceral transplant recipient

open access: yesMedical Mycology Case Reports, 2018
A case of 1-year- old male multivisceral transplant recipient with candidemia diagnosed by the T2Candida® test is presented. Optimal management of the candidemia complemented the treatment of the global clinical episode.
Iker Falces-Romero   +8 more
doaj   +1 more source

Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries

open access: yesJournal of Fungi, 2017
Candidemia, the commonest invasive fungal infection, is associated with high morbidity and mortality in developing countries, though the exact prevalence is not known due to lack of systematic epidemiological data from those countries.
Harsimran Kaur, Arunaloke Chakrabarti
doaj   +1 more source

Procalcitonin levels in candidemia versus bacteremia: a systematic review

open access: yesCritical Care, 2019
Background Procalcitonin (PCT) is a biomarker used to assess systemic inflammation, infection, and sepsis and to optimize antimicrobial therapies. Its role in the in the differential diagnosis between candidemia and bacteremia is unclear. The aim of this
Andrea Cortegiani   +6 more
doaj   +1 more source

Integrating omics techniques and culture-independent systems may improve the detection of persistent candidemia: data from an observational study

open access: yesAnnals of Clinical Microbiology and Antimicrobials
Introduction Blood cultures have low sensitivity for candidemia. Sensitivity can be improved by the culture-independent system T2 Magnetic Resonance (T2).
Anna Maria Peri   +7 more
doaj   +1 more source

Time to positivity as a diagnostic tool for catheter-related candidemia: A species-specific analysis

open access: yesInternational Journal of Infectious Diseases
Objectives: Early identification of the source of candidemia is critical for catheter management. Time to positivity (TTP) is an accessible marker of catheter-related bloodstream infection in bacteremia, but its role in candidemia remains unclear.
Marta Albanell-Fernández   +21 more
doaj   +1 more source

Factores de riesgo asociados a candidemias causadas por múltiples especies Risk factors associated with multiple-species candidemia

open access: yesRevista Argentina de Microbiología, 2008
Los episodios de candidemia han aumentado en la última década. Sin embargo, la publicación de casos de candidemias causadas por múltiples especies (CME) es infrecuente.
A. Benetucci   +4 more
doaj  

Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience

open access: yesInfection and Drug Resistance, 2015
Ryuichi Hirano,1 Yuichi Sakamoto,2 Kumiko Kudo,1 Motoki Ohnishi31Department of Pharmacy, Aomori Prefectural Central Hospital, Aomori, Japan; 2Laboratory Medicine and Blood transfusion, Aomori Prefectural Central Hospital, Aomori, Japan; 3General Medicine,
Hirano R, Sakamoto Y, Kudo K, Ohnishi M
doaj  

Predictors and Patterns of Metastatic Candidozyma auris Infection, Spain, 2016-2024. [PDF]

open access: yesEmerg Infect Dis
Suarez-Urquiza P   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy